Elodie Sauge

Pleiotropic activation of endothelial function by angiotensin II receptor blockers is crucial to their protective anti-vascular remodeling effects

Mitra Esfandiarei, P. Bernatchez, Marine Theret, 2022, Scientific Reports.

Thermoneutral Housing and a Western Diet Combination Exacerbates Dysferlin‐Deficient Muscular Dystrophy

F. Rossi, A. Devlin, P. Bernatchez, 2022, Muscle & nerve.

Losartan metabolite EXP3179 is a unique blood pressure-lowering AT1R antagonist with direct, rapid endothelium-dependent vasoactive properties.

M. Hughes, P. Bernatchez, M. Ciufolini, 2022, Vascular pharmacology.

Limb-girdle muscular dystrophy type 2B causes HDL-C abnormalities in patients and statin-resistant muscle wasting in dysferlin-deficient mice

G. Francis, P. Bernatchez, V. Straub, 2022, Skeletal Muscle.

Pleiotropic activation of endothelial function by angiotensin II receptor blockers is crucial to their protective anti-vascular remodeling effects

F. Rossi, Mitra Esfandiarei, P. Bernatchez, 2020, Scientific Reports.

Pleiotropic activation of endothelial function by angiotensin II receptor blockers is crucial to their protective anti-vascular remodeling effects

F. Rossi, Mitra Esfandiarei, P. Bernatchez, 2022, Scientific Reports.

Losartan and metabolite EXP3179 activate endothelial function without lowering blood pressure in AT2 receptor KO mice.

P. Geraldes, Farah Lizotte, Elodie Sauge, 2024, European journal of pharmacology.